Israel's Revolutionary Role in AI Drug Discovery - #0029, Mati Gill
Description
In the evolving world of healthcare and pharmaceuticals, the intersection of AI and drug discovery has become a focal point for innovation - especially in Israel. This week, I spoke to AION Labs CEO Mati Gill, who shares insights on how the venture studio is transforming the landscape of drug development through collaboration and cutting-edge technology.
Founded by global pharmaceutical partners Pfizer, AstraZeneca, Merck, and Teva, AION Labs is located in Israel and leverages AI while fostering collaboration among legacy giants, emerging startups, and local government support.
Israel’s unique position as a center for biotech innovation is underscored by its scientific research capabilities and strong tech ecosystem. We discuss how the country’s rich history of Startup Nation and advancements in life sciences create an ideal environment for new ideas to flourish. The collaboration between academia and industry is paving the way for breakthroughs in drug discovery, positioning Israel as a key player in the global pharmaceutical landscape.
Learn more about them in the video above.
Get full access to The Spiro Circle at www.thespirocircle.com/subscribe
United States
